drugset / Trial / NCT00514657

Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2

NCT00514657 ↗

Phase 2 Completed 91 enrolled Kaken Pharmaceutical
RandomizedParallel-groupDouble-blindTreatment

Summary

The present clinical trial clarified that basic fibroblast growth factor-2 (FGF-2) can induce regeneration of periodontal tissue lost by progression of periodontitis and evaluated the safety of such induction.

Timeline

Start
2001-12
Primary completion
—
Completion
2004-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Trafermin Protein / enzyme biologic 0.03 % Other
Subject Trafermin Protein / enzyme biologic 0.1 % Other
Subject Trafermin Protein / enzyme biologic 0.3 % Other

Indications